Curis | CRIS - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Alaunos Therapeutics USD -1.01M 153K 2026-03
Amgen USD 1.82B 486M 2026-03
AstraZeneca USD 3.08B 754M 2026-03
Bayer EUR 2.76B 6.52B 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
CSL USD 401M 96.5M 2025-12
Curis USD 19.36M 31.16M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Exelixis USD 210.47M 34.06M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
Incyte USD 303.33M 4.05M 2026-03
Merck USD -4.24B 7.2B 2026-03
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
Takeda JPY -24.32B 127.96B 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03
Verastem USD -32.92M 24.66M 2025-12
Xoma USD -17.24M 33.23M 2024-09